About 1 million Americans suffer from Parkinson's disease, with around 90,000 new cases diagnosed each year, according to the ...

The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS and Parkinson's.

For more than 200 years, Parkinson’s disease has been treated as a one‑way street, with drugs and devices that ease symptoms ...

Researchers have identified a key molecular interaction that accelerates Parkinson’s disease by damaging the brain’s energy ...

The RMAT designation is intended to expedite the development and evaluation of regenerative medicine therapies.

An early symptom of Parkinson’s is sleep dysfunction, according to the Journal of Clinical Sleep Medicine. Instead of ...

A team led by researchers at Chalmers University of Technology, Sweden, has succeeded in identifying biomarkers for Parkinson ...

Boston University (BU) today announced it has been awarded a $2 million research grant from The Michael J. Fox Foundation for ...

FDA fast-tracks novel Parkinson’s cell therapy NouvNeu001, advancing treatment for dopaminergic neuron loss and motor ...

Health News: Parkinson's disease is an incurable and fatal disease of the brain or nervous system. In this disease, the nerve cells in our brain start dying due to various reasons. This disease occurs ...

Metabolic syndrome was tied to a greater risk of incident Parkinson's in a large study. Risk was especially higher for those with genetic Parkinson's susceptibility. Metabolic syndrome components were ...

As the recognized uses of medical marijuana expand, more traditional research foundations are becoming interested in the possibilities of pot. On March 6 and 7, the Parkinson’s Foundation will host ...